Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 264Glioblastoma 245Glioma 187Neuroblastoma 83Neoplasms 58Central Nervous System Neoplasms 53Astrocytoma 53Medulloblastoma 45Breast Neoplasms 42Sarcoma 38Melanoma 38Carcinoma, Non-Small-Cell Lung 37Neurofibromatosis 1 36Meningioma 35Ependymoma 35Lung Neoplasms 34Osteosarcoma 29Rhabdomyosarcoma 28Diffuse Intrinsic Pontine Glioma 27Sarcoma, Ewing 26Recurrence 26Rhabdoid Tumor 25Neoplasm Metastasis 25Oligodendroglioma 22Wilms Tumor 21Gliosarcoma 21Pancreatic Neoplasms 20Pheochromocytoma 19Hepatoblastoma 19Thyroid Neoplasms 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vipoma × CNS × 90 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡